Articular cartilage has a very limited self-repairing capacity; thus, chond
ral lesions normally result in chronic degeneration and, eventually, osteoa
rthritis development. Currently, tissue engineering offers a new tool for t
he clinical treatment of osteochondral defects. The present investigation a
imed to develop an in vitro engineered cartilage using a new class of semis
ynthetic scaffolds. Two nonwoven meshes of hyaluronan esters (Hyaff(R) deri
vatives) were seeded with sternal chick embryo chondrocytes cultured for up
to 21 days, after which time they were assessed for both the cellular grow
th profile and histological features. Avian chondrocytes easily adhered and
proliferated onto hyaluronan-based scaffolds, demonstrating a significant
preference for the fully esterified benzylic form. Histochemical staining r
evealed the presence of a neosynthesized glycosaminoglycan-rich extracellul
ar matrix, and immunohistochemistry confirmed the deposition of collagen ty
pe II. Moreover, ultrastructural observations supported evidence that chond
rocytes grown onto a hyaluronan-derived three-dimensional scaffold maintain
ed their unique phenotype and organization in a cartilage-like extracellula
r matrix. These findings support the further pursuit of a transplantable en
gineered cartilage using human chondrocytes for the regeneration of chondra
l lesions. (C) 1999 John Wiley & Sons, Inc. J Biomed Mater Res, 46, 337-346
, 1999.